Mitchell E. Taub
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 14
- Drug-Induced Hepatotoxicity and Protection 5
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 31
-
- Pharmacological Effects and Toxicity Studies 12
- Pharmaceutical Science top 5%
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 9
-
- Metabolism and Genetic Disorders 5
-
- HIV/AIDS drug development and treatment 5
-
- Gastroesophageal reflux and treatments 3
- Co-authors
- Lalitha PodilaSven FrøkjærMaciej J. Zamek‐GliszczynskiThomas EbnerRucha SaneHarma EllensBente SteffansenNaoki Ishiguro
- Journals
- Drug Metabolism and Disposition (12 papers)Pharmaceutical Research (5 papers)European Journal of Pharmaceutical Sciences (5 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Mitchell E. Taub
47 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Pharmacology 390
- Oncology 908
- Pediatrics, Perinatology and Child Health 464
- Pharmaceutical Science 109
- Biochemistry 86
Countries citing papers authored by Mitchell E. Taub
This map shows the geographic impact of Mitchell E. Taub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Taub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Taub more than expected).
Fields of papers citing papers by Mitchell E. Taub
This network shows the impact of papers produced by Mitchell E. Taub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Taub. The network helps show where Mitchell E. Taub may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mitchell E. Taub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2020 | 45 | |
| 9 | 2020 | 11 | |
| 10 | 2018 | 157 | |
| 11 | 2018 | 4 | |
| 12 | 2015 | 58 | |
| 13 | 2015 | 108 | |
| 14 | 2013 | 56 | |
| 15 | 2011 | 22 | |
| 16 | 2005 | 103 | |
| 17 | 2002 | 58 | |
| 18 | 2001 | 13 | |
| 19 | 2001 | 54 | |
| 20 | 1992 | 13 |
About Mitchell E. Taub
Mitchell E. Taub is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (14 papers), Pharmacological Effects and Toxicity Studies (12 papers), Amino Acid Enzymes and Metabolism (9 papers), Metabolism and Genetic Disorders (5 papers), HIV/AIDS drug development and treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Pharmacology (390 citations), Oncology (908 citations) and Pediatrics, Perinatology and Child Health (464 citations). Mitchell E. Taub has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Lalitha Podila, Sven Frøkjær, Maciej J. Zamek‐Gliszczynski, Thomas Ebner, Rucha Sane, Harma Ellens, Bente Steffansen, Naoki Ishiguro, Xiaoyan Chu and Donald Tweedie. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Journal of Pharmaceutical Sciences and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.